| Prostate-specific antigen, risk factors, and prostate cancer: confounders nestled in an enigma. | |
| | |
MedLine Citation:
|
PMID: 20724727 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
|
Authors:
|
Ian M Thompson; Donna P Ankerst; Catherine M Tangen |
Related Documents
:
|
15647927 - Immunotherapy with autologous antigen presenting cells for the treatment of androgen in... 19835577 - Lack of evidence for xenotropic murine leukemia virus-related virus(xmrv) in german pro... 16891207 - Metastatic ductal adenocarcinoma of the prostate: cytologic features and clinical findi... 1246767 - Serum proteins in prostatic cancer. iii. relationship of levels of immunoglobulins and ... 1732927 - The art of mammographic positioning. 15258337 - Seldi-tof serum profiling for prognostic and diagnostic classification of breast cancers. |
Publication Detail:
|
Type: Comment; Editorial Date: 2010-08-19 |
Journal Detail:
|
Title: Journal of the National Cancer Institute Volume: 102 ISSN: 1460-2105 ISO Abbreviation: J. Natl. Cancer Inst. Publication Date: 2010 Sep |
Date Detail:
|
Created Date: 2010-09-08 Completed Date: 2010-09-28 Revised Date: 2013-05-28 |
Medline Journal Info:
|
Nlm Unique ID: 7503089 Medline TA: J Natl Cancer Inst Country: United States |
Other Details:
|
Languages: eng Pagination: 1299-301 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Confounding Factors (Epidemiology) Early Detection of Cancer* / methods Humans Male Prostate-Specific Antigen / blood* Prostatic Neoplasms / diagnosis*, epidemiology, genetics*, immunology Risk Assessment Risk Factors Sweden / epidemiology Tumor Markers, Biological / blood* |
| Chemical | |
Reg. No./Substance:
|
0/Tumor Markers, Biological; EC 3.4.21.77/Prostate-Specific Antigen |
| Comments/Corrections | |
Comment On:
|
J Natl Cancer Inst. 2010 Sep 8;102(17):1336-43
[PMID:
20724726
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Effects of Prostate-Specific Antigen Testing on Familial Prostate Cancer Risk Estimates.
Next Document: Complement-dependent transport of antigen into B cell follicles.